This website uses cookies to store user session information. By using our website you consent to our terms of use. Read more
I agree
10.02.1979
denis.kaynov@ut.ee
01.01.2000−01.01.2009 Kainov, Denis
Denis Kainov received his PhD in Genetics from the University of Helsinki in 2005. He performed his postdoctoral training in IGBMC, France and in CRP-Sante, Luxembourg during 2005-2009. He then returned to Finland, and worked as FIMM-EMBL group leader during 2010-2016.​ He is now working as senior reearcher at TUIT. His group develops novel modalities against viral diseases.

Career

Institution and occupation
01.11.2017–30.06.2022   
University of Tartu, Faculty of Science and Technology, Institute of Technology, Senior Research Fellow in Virology (0,75)
2010–2016   
Institute for Molecular Medicine Finland, FIMM, Senior Researcher (100,00)
2007–2009   
Luxembourg Institute of Health, Post-Doc (100,00)
2005–2007   
Institut de Génétique et de Biologie Moléculaire et Cellulaire, Post-Doc (100,00)
2001–2005   
Institute of Biotechnology, Finland, Researcher (100,00)
2000–2001   
Moscow State University branch in Puschino, Technical staff (100,00)
 
 
Education
01.01.2001–31.12.2005   
PhD in Genetics
 
 
R&D related managerial and administrative work
2010−...   
Grant evaluator for Medical Research Council, UK; Medical Research Council, Israel, The Netherlands Organization for Health Research and Development as well as for several Finnish foundations; invited speaker and chair at number of international meetings; ad hoc examiner for PhD students in Singapore and Finland; reviewing Editor at Frontiers in Cell and Dev. Biol., Guest Editor in Frontiers in Biosciences, Active reviewer for Mol. Microbiol., Emerging Microbes & Infections, NAR, Viruses, Virulence, TiPS, PloS One
2010−...   
Grants: 2019-2023 RCN, Globvac (subcontractor), TBA NOK • 2017-2021 European Regional Development Fund, Mobilitas Pluss grant, 903,000 euros • 2015-2017 University of Helsinki three year research grant, 150,000 euros • 2010-2015 J&A Erkko Foundation, 1,000,000 euros • 2013-2015 Research Council of Lithuania, 298,000 euros • 2012-2014 Academy of Finland/SHOK, 136,208 euros
 
 
Creative work
Examples of our press releases:
2018: Exploring new uses for existing anti-viral drugs (https://geminiresearchnews.com/2018/04/exploring-new-uses-existing-antiviral-drugs/).
2016: A new model system to study the effect of antiviral drugs and drug candidates on innate immunity (www.fimm.fi/en/news/1452517963)
2015: A new approach to predict evolution of influenza viruses can enhance vaccine efficacy (www.fimm.fi/en/press-release/1449504710)
2012: Harnessing anticancer drugs for the future fight against influenza (www.sciencedaily.com/releases/2012/09/120905083903.htm).

Qualifications

 
 
Honours & awards
2006, Denis Kaynov, Young investigator award IUBMB
2005, Denis Kaynov, EMBO LTF
2005, Denis Kaynov, Best PhD thesis award
2004, Denis Kaynov, FEBS STF
 
 
Field of research
FIELD OF RESEARCH: 1. Biosciences and Environment; 1.2. Microbiology; CERCS SPECIALTY: B230 Microbiology, bacteriology, virology, mycology
 
 
Additional information
Translator in professional communications (2001)

Supervision of postdoctoral researchers

  • 01.01.2013−31.12.2016    Laura Kakkola  "Microbiology" (University of Helsinki)
  • 01.01.2014−31.12.2015    Johanna Lampe  "Microbiology" (University of Helsinki)

Publications

Category
Year
Publication
 
1.1.
2018
1.1.
2018
1.1.
2018
1.1.
2017
1.1.
2017
1.1.
2017
1.1.
2017
1.1.
2016
1.1.
2016
1.1.
2016
1.1.
2016
1.1.
2016
1.1.
2016
1.1.
2016
1.1.
2016
1.1.
2016
1.1.
2016
1.1.
2015
1.1.
2015
1.1.
2015
1.1.
2015
1.1.
2015
1.1.
2015
1.2.
2015
1.1.
2014
1.1.
2014
1.1.
2014
1.1.
2014
1.1.
2014
1.1.
2014
1.1.
2013
1.1.
2013
1.1.
2013
1.1.
2013
1.1.
2012
1.1.
2012
1.1.
2012
1.1.
2011
1.1.
2011
1.1.
2010
1.1.
2010
1.1.
2008
1.1.
2008
1.1.
2007
1.1.
2006
1.1.
2006
1.1.
2005
1.1.
2004
1.1.
2004
1.1.
2004
1.1.
2003
1.1.
2003
1.1.
2003
12.06.2019
10.02.1979
denis.kaynov@ut.ee
01.01.2000−01.01.2009 Kainov, Denis

Teenistuskäik

Töökohad ja ametid
01.11.2017–30.06.2022   
Tartu Ülikool, Loodus- ja täppisteaduste valdkond, tehnoloogiainstituut, viroloogia vanemteadur (0,75)
2010–2016   
Institute for Molecular Medicine Finland, FIMM, Vanemteadur (100,00)
2007–2009   
Luxembourg Institute of Health, Järeldoktor (100,00)
2005–2007   
Institut de Génétique et de Biologie Moléculaire et Cellulaire, Järeldoktor (100,00)
2001–2005   
Institute of Biotechnology, Finland, Teadur (100,00)
2000–2001   
Moscow State University branch in Puschino, Tehniline töötaja (100,00)
 
 
Haridustee
01.01.2001–31.12.2005   
PhD in Genetics
 
 
Teadusorganisatsiooniline ja -administratiivne tegevus
2010−...   
Grant evaluator for Medical Research Council, UK; Medical Research Council, Israel, The Netherlands Organization for Health Research and Development as well as for several Finnish foundations; invited speaker and chair at number of international meetings; ad hoc examiner for PhD students in Singapore and Finland; reviewing Editor at Frontiers in Cell and Dev. Biol., Guest Editor in Frontiers in Biosciences, Active reviewer for Mol. Microbiol., Emerging Microbes & Infections, NAR, Viruses, Virulence, TiPS, PloS One
2010−...   
Grants: 2019-2023 RCN, Globvac (subcontractor), TBA NOK • 2017-2021 European Regional Development Fund, Mobilitas Pluss grant, 903,000 euros • 2015-2017 University of Helsinki three year research grant, 150,000 euros • 2010-2015 J&A Erkko Foundation, 1,000,000 euros • 2013-2015 Research Council of Lithuania, 298,000 euros • 2012-2014 Academy of Finland/SHOK, 136,208 euros
 
 
Loometöö
Examples of our press releases:
2018: Exploring new uses for existing anti-viral drugs (https://geminiresearchnews.com/2018/04/exploring-new-uses-existing-antiviral-drugs/).
2016: A new model system to study the effect of antiviral drugs and drug candidates on innate immunity (www.fimm.fi/en/news/1452517963)
2015: A new approach to predict evolution of influenza viruses can enhance vaccine efficacy (www.fimm.fi/en/press-release/1449504710)
2012: Harnessing anticancer drugs for the future fight against influenza (www.sciencedaily.com/releases/2012/09/120905083903.htm).

Kvalifikatsioon

 
 
Teaduspreemiad ja tunnustused
2006, Denis Kaynov, Young investigator award IUBMB
2005, Denis Kaynov, EMBO LTF
2005, Denis Kaynov, Best PhD thesis award
2004, Denis Kaynov, FEBS STF
 
 
Teadustöö põhisuunad
VALDKOND: 1. Bio- ja keskkonnateadused; 1.2. Mikrobioloogia; CERCS ERIALA: B230 Mikrobioloogia, bakterioloogia, viroloogia, mükoloogia
 
 
Lisainfo
Docentship in infection biology from UH (2011)
Translator in professional communications (with honour)

Juhendatud järeldoktorid

  • 01.01.2013−31.12.2016 Laura Kakkola "Microbiology" University of Helsinki
  • 01.01.2014−31.12.2015 Johanna Lampe "Microbiology" University of Helsinki

Publikatsioonid

Klass
Aasta
Publikatsioon
 
1.1.
2018
1.1.
2018
1.1.
2018
1.1.
2017
1.1.
2017
1.1.
2017
1.1.
2017
1.1.
2016
1.1.
2016
1.1.
2016
1.1.
2016
1.1.
2016
1.1.
2016
1.1.
2016
1.1.
2016
1.1.
2016
1.1.
2016
1.1.
2015
1.1.
2015
1.1.
2015
1.1.
2015
1.1.
2015
1.1.
2015
1.2.
2015
1.1.
2014
1.1.
2014
1.1.
2014
1.1.
2014
1.1.
2014
1.1.
2014
1.1.
2013
1.1.
2013
1.1.
2013
1.1.
2013
1.1.
2012
1.1.
2012
1.1.
2012
1.1.
2011
1.1.
2011
1.1.
2010
1.1.
2010
1.1.
2008
1.1.
2008
1.1.
2007
1.1.
2006
1.1.
2006
1.1.
2005
1.1.
2004
1.1.
2004
1.1.
2004
1.1.
2003
1.1.
2003
1.1.
2003
12.06.2019
  • Found 1 results
ProgramTypeNumberNameProject startProject endPrincipal investigatorInstitutionFinancing
MOBTTMOBTT39Towards better diagnostics and treatment of severe influenza infections01.07.201730.06.2022Denis KaynovUniversity of Tartu, Faculty of Science and Technology, Institute of Technology749 581,30 EUR